SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001016169-10-000002
Filing Date
2010-03-24
Accepted
2010-03-23 18:03:07
Documents
10
Period of Report
2009-12-31
Filing Date Changed
2010-03-23

Document Format Files

Seq Description Document Type Size
1 k10.htm 10-K 1838346
2 transdermal10k09.jpg GRAPHIC 57356
3 performancegraph09.jpg GRAPHIC 64841
4 ex211.htm EX-21.1 7913
5 ex231.htm EX-23.1 5089
6 ex311.htm EX-31.1 18608
7 ex312.htm EX-31.2 20644
8 ex321.htm EX-32.1 8609
9 ex322.htm EX-32.2 8624
10 injectiontable2009.jpg GRAPHIC 68594
  Complete submission text file 0001016169-10-000002.txt   2172837
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-K | Act: 34 | File No.: 001-32302 | Film No.: 10700115
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10